HMGN (Hemagen Diagnostics) Cyclically Adjusted Book per Share: $0.00 (As of Sep. 2012)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Hemagen Diagnostics Cyclically Adjusted Book per Share?

Hemagen Diagnostics HMGN Cyclically Adjusted Book per Share is $0.00 as of Sep. 2012.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Hemagen Diagnostics's adjusted book value per share for the three months ended in Sep. 2012 was $-0.228. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.00 for the trailing ten years ended in Sep. 2012.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-09-01), Hemagen Diagnostics's current stock price is $0.0002. Hemagen Diagnostics's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2012 was $0.00. Hemagen Diagnostics's Cyclically Adjusted PB Ratio of today is .


Hemagen Diagnostics  (OTCPK:HMGN) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Hemagen Diagnostics Cyclically Adjusted Book per Share Related Terms


Hemagen Diagnostics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Hemagen Diagnostics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hemagen Diagnostics Cyclically Adjusted Book per Share Chart

Hemagen Diagnostics Annual Data
Trend Sep03 Sep04 Sep05 Sep06 Sep07 Sep08 Sep09 Sep10 Sep11 Sep12
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Hemagen Diagnostics Quarterly Data
Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

HMGN vs OBMP, NSPX, ATRX: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Hemagen Diagnostics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hemagen Diagnostics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemagen Diagnostics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Hemagen Diagnostics's Cyclically Adjusted PB Ratio falls into.



Hemagen Diagnostics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hemagen Diagnostics's adjusted Book Value per Share data for the three months ended in Sep. 2012 was:

Adj_Book= Book Value per Share /CPI of Sep. 2012 (Change)*Current CPI (Sep. 2012)
=-0.228/231.4070*231.4070
=-0.228

Current CPI (Sep. 2012) = 231.4070.

Hemagen Diagnostics Quarterly Data

Book Value per Share CPI Adj_Book
200212 0.280 180.900 0.358
200303 0.236 184.200 0.296
200306 0.199 183.700 0.251
200309 0.190 185.200 0.237
200312 0.133 184.300 0.167
200403 0.095 187.400 0.117
200406 0.024 189.700 0.029
200409 0.026 189.900 0.032
200412 0.001 190.300 0.001
200503 -0.024 193.300 -0.029
200506 -0.036 194.500 -0.043
200509 -0.067 198.800 -0.078
200512 -0.059 196.800 -0.069
200603 -0.063 199.800 -0.073
200606 -0.071 202.900 -0.081
200609 -0.047 202.900 -0.054
200612 -0.070 201.800 -0.080
200703 -0.089 205.352 -0.100
200706 -0.097 208.352 -0.108
200709 -0.098 208.490 -0.109
200712 -0.046 210.036 -0.051
200803 -0.043 213.528 -0.047
200806 -0.043 218.815 -0.045
200809 -0.072 218.783 -0.076
200812 -0.098 210.228 -0.108
200903 -0.107 212.709 -0.116
200906 -0.109 215.693 -0.117
200909 -0.117 215.969 -0.125
200912 -0.120 215.949 -0.129
201003 -0.118 217.631 -0.125
201006 -0.118 217.965 -0.125
201009 -0.119 218.439 -0.126
201012 -0.129 219.179 -0.136
201103 -0.149 223.467 -0.154
201106 -0.147 225.722 -0.151
201109 -0.172 226.889 -0.175
201112 -0.196 225.672 -0.201
201203 -0.208 229.392 -0.210
201206 -0.220 229.478 -0.222
201209 -0.228 231.407 -0.228

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $0.00 mean?
Hemagen Diagnostics (HMGN) has a Cyclically Adjusted Book per Share of $0.00 as of Sep. 2012. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Hemagen Diagnostics and its competitors.
Is Hemagen Diagnostics' Cyclically Adjusted Book per Share too high?
Hemagen Diagnostics' current Cyclically Adjusted Book per Share is $0.00.
How does Hemagen Diagnostics' Cyclically Adjusted Book per Share compare to OBMP and NSPX?
Hemagen Diagnostics' Cyclically Adjusted Book per Share of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Hemagen Diagnostics and its competitors. Hemagen Diagnostics's current Cyclically Adjusted Book per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemagen Diagnostics stock overvalued right now?
Hemagen Diagnostics (HMGN) has a current Cyclically Adjusted Book per Share of $0.00. The current Cyclically Adjusted Book per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Hemagen Diagnostics (HMGN), the current Cyclically Adjusted Book per Share is $0.00 as of Sep. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hemagen Diagnostics Business Description

Address 9033 Red Branch Road, Columbia, MD, USA, 21045
Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.